SCANPHARM A/S: Financial statements 2016
CVR: 16279099
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 19,626,649 and a net result of DKK 1,267,088 compared with DKK 715,522 the year before. That is a decrease of 4% compared with the year before. Equity amounted to DKK 12,971,605. The solvency ratio was 38.8%. The company had 42 employees in the financial year.
- Gross Profit
- 19,626,649 kr.
- Profit/Loss
- 1,267,088 kr.
- Equity
- 12,971,605 kr.
- Total Assets
- 33,401,535 kr.
- Employees
- 42
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 19.6 mio. | 1.3 mio. | 13 mio. | 42 |
| 2015 | - | 20.4 mio. | 716 t. | 11.7 mio. | 42 |
| 2014 | - | 20.8 mio. | 431 t. | 11 mio. | - |
| 2013 | - | 20.9 mio. | 400 t. | 10.6 mio. | - |
How creditworthy is SCANPHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
SCANPHARM A/S has published its annual report for 2015. Gross profit came to DKK 20,446,816, and the net result was DKK 715,522.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees. In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity amounted to DKK 3,045,406.
